Osaka, Japan

Matsuhiko Aratari

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1982.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matsuhiko Aratari. Retrieved from https://idiyas.com/inventor/matsuhiko-aratari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matsuhiko Aratari: Innovator in Antimicrobial Compositions

Introduction

Matsuhiko Aratari is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial agents. His work has implications for improving health outcomes through innovative drug formulations.

Latest Patents

Aratari holds a patent for "Cephalosporin analogues and antimicrobial compositions." This invention relates to cephalosporin analogues and pharmaceutically acceptable salts thereof, which exhibit high antimicrobial activity. His innovative approach in this area has the potential to enhance the effectiveness of treatments against various infections.

Career Highlights

Matsuhiko Aratari is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in advancing pharmaceutical research and development. His expertise in antimicrobial compositions has positioned him as a key figure in the industry.

Collaborations

Throughout his career, Aratari has collaborated with esteemed colleagues, including Misashi Hashimoto and Keiji Hemmi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Matsuhiko Aratari's contributions to antimicrobial compositions highlight his role as a significant inventor in the pharmaceutical industry. His work continues to influence the development of effective treatments, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…